Research!America Honors Lindberg
|NLM director Dr. Donald Lindberg with an artwork based on the NLM Visible Human Project
Research!America paid tribute to some of the nation’s foremost medical and health research advocates at its 16th annual Advocacy Awards on Mar. 14. Among those recognized was Dr. Donald Lindberg, director of the National Library of Medicine and former director of the White House High Performance Computing and Communications Program. He received the 2012 Geoffrey Beene Builders of Science Award for pioneering the application of computer technology to medicine and for his contributions to information and computer activities in medical diagnosis, artificial intelligence and educational programs. The Beene Award is part of a 5-year commitment in recognizing those who have provided inspiration and determination in building an outstanding home for research.
Other 2012 Advocacy Award winners are: Sen. Barbara Mikulski (D-MD); Dr. Sanjay Gupta, chief medical correspondent, CNN; Dr. Margaret Foti, CEO, American Association for Cancer Research; Scott Johnson, president and founder, Myelin Repair Foundation; and the Food Allergy Initiative.
Lewis Appointed NINDS Executive Officer
NINDS recently welcomed Caroline Lewis as its new executive officer. She will oversee NINDS’s financial management, human resources, information technology and administrative services and analysis activities.
Lewis comes to NINDS from the Food and Drug Administration, where she had been deputy chief operating officer since April 2010. In that role she oversaw a $3.2 billion budget and a workforce of more than 14,000 while working to protect the health of the nation’s consumers from harm by food, drugs, biological products, medical devices, tobacco and other consumer products.
“Ms. Lewis brings with her a wealth of administrative expertise and an extensive background in federal management,” said NINDS director Dr. Story Landis. “Her leadership skills and experience make her exceptionally well qualified for her new role at NINDS.”
Before joining FDA, Lewis served in a variety of professional administrative and program leadership positions at the Health Resources and Services Administration, including deputy associate administrator of the Office of Administration and Financial Management, director of the Office of Management and deputy associate administrator for clinician recruitment and service.
Lewis received her undergraduate degree from Duke University and her master’s from Georgetown University before beginning a career of public service as a statistician at the National Center for Health Statistics.
Rogan Honored by American Academy Of Pediatrics
NIEHS epidemiologist Dr. Walter Rogan has been named an honorary fellow of the American Academy of Pediatrics for his exemplary service with the organization’s Council on Environmental Health. Currently the head of an NIEHS group studying children’s health, Rogan has been a lead scientist and expert in the fields of environmental health and pediatrics for nearly four decades.
Because of his work on several key pediatric issues, ranging from lead poisoning and well water safety, to the potentially harmful effects of soy-based infant products, Rogan is regarded as an authority on the influence of environment on human growth and development. In addition to his peer-reviewed publications on child health, he has authored a number of AAP’s educational and policy materials, including several chapters in its Handbook of Environmental Health, otherwise known as the Green Book.
“AAP is pleased to recognize Dr. Rogan for his incredible work in the field of children’s environmental health, as well as his longevity as a valued member of this committee,” said Dr. Jerome Paulson, chair of AAP’s executive committee on environmental health. Rogan will be honored at AAP’s May 21 meeting in Washington, D.C.
Zahm, NCI’s DCEG Deputy Director, Retires
|Dr. Shelia Hoar Zahm
Dr. Shelia Hoar Zahm, deputy director of the Division of Cancer Epidemiology and Genetics, NCI, recently retired after 31 years of government service. She received numerous awards for her scientific accomplishments and leadership skills. Said DCEG director Dr. Joseph F. Fraumeni, Jr., she was a “full partner in leading the division as we grew and changed in response to new scientific opportunities and challenges.”
An internationally acclaimed epidemiologist, Zahm received her doctorate in epidemiology from Harvard School of Public Health, where she created the first job-exposure matrix, which continues to be used for assessing exposure in occupational studies. She joined NCI in 1980, investigating the etiology of non-Hodgkin lymphoma and other cancers in what was then called the Occupational Epidemiology Branch. The author of more than 270 publications, she contributed to understanding lymphoid malignancy, risks associated with pesticide use and occupational cancer among women.
Beginning with her appointment as deputy director in 1998, Zahm led strategic planning and management for the division. She oversaw virtually all major DCEG initiatives.
She co-chaired the NIH scientific directors’ subcommittee on biorepository practices and guidelines for the NIH intramural research program, for which she won an NIH Director’s Award.
Said Dr. Michael Gottesman, NIH deputy director for intramural research, “Shelia is one of those rare people who bring extraordinary creativity not only to their science, but to their management of scientific programs. NIH could always count on her for a thoughtful, effective and efficient solution to the many problems that she was asked to solve.”
Zahm served on more than 50 advisory committees, including panels for international research centers in Spain and Canada, the United Auto Workers/General Motors occupational health advisory board and the HHS interagency breast cancer and environmental research coordinating committee. She also won the HHS Secretary’s Award for Distinguished Service for leadership of national research programs in environmental and occupational cancers and the Harvard School of Public Health Alumni Award of Merit.
According to Fraumeni, “The success of the DCEG research and training enterprise can be traced in so many ways to the inspiring leadership of Shelia Zahm. Few individuals have made such an impact in furthering the mission of NCI and NIH, and none with more grace and humor.”
NIDDK Council Gains Four
|Four new NIDDK advisory council members recently began their service. They are (from l) Dr. Robert Vigersky, John W. Walsh, Dr. Kenneth Kaushansky and Dr. Alan Shuldiner. At right is NIDDK director Dr. Griffin Rodgers.
Four new members recently joined NIDDK’s advisory council:
Dr. Alan Shuldiner is the John Whitehurst professor of medicine; associate dean for personalized medicine, director of the Program for Personalized Medicine and head of the division of endocrinology, diabetes and nutrition at the University of Maryland School of Medicine. His research interests include the molecular basis and genetics of type 2 diabetes, obesity and insulin resistance.
Dr. Robert Vigersky is a colonel in the medical corps at Walter Reed Army Medical Center, medical director of the Diabetes Institute of the Walter Reed Health Care System and a professor in the department of medicine at the Uniformed Services University of the Health Sciences. He has produced articles and book chapters on topics ranging from reproductive endocrinology and diabetes management to telemedicine and e-health.
John W. Walsh co-founded the Alpha-1 Foundation to provide leadership and resources to improve detection and treatment, and to find a cure, for alpha-1 antitrypsin deficiency. He regularly testifies before Congress and advisory groups as a patient advocate and served three terms on the HHS advisory committee on blood safety and availability, among many other positions.
Dr. Kenneth Kaushansky is dean of the School of Medicine and senior vice president of health sciences at Stony Brook University. He has conducted seminal research on the molecular biology of blood cell production and his team has cloned several genes important in the growth and differentiation of blood cells, including thrombopoietin, a key regulator of cell and platelet production.